The antiviral drug remdesivir reduces the risk of death for severely ill coronavirus patients by 62 percent, the company that makes it said Friday. Gilead Sciences said the use of the medication was linked to “significantly improved clinical recovery” in a study of hundreds of clinical trial patients, which will be presented to scientists at…
Source: NY Post click here for more…
Study shows drug remdesivir lowers death risk for COVID-19 patients by 62%
Published in New York City
More from New York CityMore posts in New York City »
- John Harbaugh isn’t worried about his Ravens job security with season nearly lost
- JD Vance trains with Navy SEALs in California: ‘Feel like I got hit by a freight train’
- It’s undeniable US allowed child trafficking during Afghan withdrawal — now’s the time to make it right
- Goodbye (and Good Riddance?) to the MetroCard
- Bernie Sanders to Lead Zohran Mamdani’s Public Swearing-In Ceremony
Be First to Comment